Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation

Journal of Virology

Volumn 77, Issue 5, 2003, Pages 3319-3325

  Davis, David A ^a   Brown, Cara A ^a   Newcomb, Fonda M ^a,d   Boja, Emily S ^b   Fales, Henry M ^b   Kaufman, Joshua ^c   Stahl, Stephen J ^c   Wingfield, Paul ^c   Yarchoan, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d PERKINELMER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; PROTEINASE; SULFUR; VIRUS ENZYME;

ARTICLE; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROVIRUS; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; VIRUS MORPHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ENDOPEPTIDASES; CATS; CATTLE; DIMERIZATION; ENDOPEPTIDASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, VIRAL; HIV PROTEASE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; RETROVIRIDAE; SEQUENCE ALIGNMENT;

EID: 0037370725     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.5.3319-3325.2003     Document Type: Article

References (25)

1. Adams, L. D., A. G. Tomasselli, P. Robbins, B. Moss, and R. L. Heinrikson. 1992. HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res. Hum. Retrovir. 8:291-295.
2. Davis, D. A., F. M. Newcomb, J. Moskovitz, P. T. Wingfield, S. J. Stahl, J. Kaufman, H. M. Fales, R. L. Levine, and R. Yarchoan. 2000. HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. Biochem. J. 346:305-311.
3. Davis, D. A., F. M. Newcomb, D. W. Starke, D. E. Ott, J. M. Mieyal, and R. Yarchoan. 1997. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 272:25935-25940.
4. Davis, D. A., K. Yusa, L. A. Gillim, F. M. Newcomb, H. Mitsuya, and R. Yarchoan. 1999. The conserved cysteines of the human immunodeficiency type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions. J. Virol. 13:1156-1164.
5. Grant, S. K., I. C. Deckman, J. S. Culp, M. D. Minnich, and I. S. Brooks. 1992. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases. Biochemistry 31:9491-9501.
6. Gustchina, A., J. Kervinen, D. J. Powell, A. Zdanov, J. Kay, and A. Wlodawer. 1996. Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci. 5:1453-1465.
7. Katz, R. A., and A. M. Skalka. 1994. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173.
8. Louis, J. M., S. Oroszlan, and J. Tozser. 1999. Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase. J. Biol. Chem. 274:6660-6666.
9. Luukkonen, B. G., E. M. Fenyo, and S. Schwartz. 1995. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity. Virology 206:854-865.
10. Mildner, A. M., D. J. Rothrock, J. W. Leone, C. A. Bannow, J. M. Lull, I. M. Reardon, J. L. Sarcich, W. J. Howe, C. S. Tomich, C. W. Smith, et al. 1994. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry 33:9405-9413.
11. Parker, S. D., and E. Hunter. 2001. Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro. Proc. Natl. Acad. Sci. USA 98:14631-14636.
12. Riviere, Y., V. Blank, P. Kourilsky, and A. Israel. 1991. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature 350:625-626.
13. Sayle, R. A., and E. J. Milner-White. 1995. RASMOL: biomolecular graphics for all. Trends Biochem. Sci. 20:374.
14. Shoeman, R. L., C. Kesselmier, E. Mothes, B. Honer, and P. Traub. 1991. Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett. 278:199-203.
15. Snasel, J., R. Shoeman, M. Horejsi, O. Hruskova-Heidingsfeldova, J. Sedlacek, T. Ruml, and I. Pichova. 2000. Cleavage of vimentin by different retroviral proteases. Arch. Biochem. Biophys. 377:241-245.
16. Strack, P. R., M. W. Frey, C. J. Rizzo, B. Cordova, H. J. George, R. Meade, S. P. Ho, J. Corman, R. Tritch, and B. D. Korant. 1996. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA 93:9571-9576.
17. Todd, M. J., N. Semo, and E. Freire. 1998. The structural stability of the HIV-1 protease. J. Mol. Biol. 283:475-488.
18. Tomasselli, A., J. O. Hui, L. Adams, J. Chosay, D. Lowery, B. Greenberg, A. Yem, M. R. Deibel, H. Zurcher-Neely, and R. L. Heinrikson. 1991. Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1B as substrates of the protease from human immunodeficiency virus. J. Biol. Chem. 266:14548-14553.
19. Tozser, J., G. Zahuczky, P. Bagossi, J. M. Louis, T. D. Copeland, S. Oroszlan, R. W. Harrison, and I. T. Weber. 2000. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases. Eur. J. Biochem. 267:6287-6295.
20. Vallette, F., E. Mege, A. Reiss, and M. Adesnik. 1989. Construction of mutant and chimeric genes using the polymerase chain reaction. Nucleic Acids Res. 17:723-733.
21. Ventoso, I., R. Blanco, C. Perales, and L. Carrasco. 2001. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc. Natl. Acad. Sci. USA 98:12966-12971.
22. Wang, Y. X., D. I. Freedberg, T. Yamazaki, P. T. Wingfield, S. J. Stahl, J. D. Kaufman, Y. Kiso, and D. A. Torchia. 1996. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. Biochemistry 35: 9945-9950. (Erratum, 36:280, 1997.)
23. Woody, R. W. 1995. Circular dichroism. Methods Enzymol. 246:34-71.
24. Xie, D., S. Gulnik, E. Gustchina, B. Yu, W. Shao, W. Qoronfleh, A. Nathan, and J. W. Erickson. 1999. Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH. Protein Sci. 8:1702-1707.
25. Yasuda, J., and E. Hunter. 1998. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J. Virol. 72:4095-4103.